Cannabis can provide patients benefits for pain and symptom management, improve their functionality, and enhance their well-being. Yet restrictive medical cannabis programs can limit these potential benefits. This article draws on four years of research into Minnesota’s medical cannabis program—one of the most restrictive in the United States—including in-depth interviews with patients and a survey of health care professionals. Drawing on the new materialist concepts of Deleuze and Guattari, this article analyzes (a) the benefits patients in Minnesota’s medical cannabis program derive from cannabis, (b) how program restrictions mediate access to cannabis and its derived benefits, and (c) some key ways in which medical and criminal justice institutional authorities are reconfigured around medical cannabis. I show how the imperative to authoritatively govern “dangerous drugs” persists in consequential ways as the War on Drugs shifts toward a medicalized, criminalized, and commercial-legalized mixed regime.
AaronsonElyRothschild-ElyassiGil. 2021. “The Symbiotic Tensions of the Regulatory–Carceral State: The Case of Cannabis Legalization.” Regulation and Governance15(S1):S23–39.
2.
AcevedoBeatriz. 2007. “Creating the Cannabis User: A Poststructuralist Analysis of the Reclassification of Cannabis in the United Kingdom (2004–2005).” International Journal of Drug Policy18(3):177–86.
3.
AlexanderMichelle. 2010. The New Jim Crow: Mass Incarceration in the Age of Colorblindness. New York, NY: The New Press.
BaldacchinoAlexGilchristGailFlemingRodBannisterJonathan. 2010. “Guilty until Proven Innocent: A Qualitative Study of the Management of Chronic Noncancer Pain among Patients with a History of Substance Abuse.” Addictive Behaviors35(3):270–72.
7.
BeachMary CatherineSahaSomnathParkJennyTaylorJanieceDrewPaulPlankEveCooperLisa A.CheeBrant. 2021.“Testimonial Injustice: Linguistic Bias in the Medical Records of Black Patients and Women.” Journal of General Internal Medicine36(6):1708–14.
8.
BlairIrene V.SteinerJohn F.FaircloughDiane L.HanrattyRebeccaPriceDavid W.HirshHolen K.WrightLeslie A., et al. 2013. “Clinicians’ Implicit Ethnic-Racial Bias and Perceptions of Care among Black and Latino Patients.” The Annals of Family Medicine11(1):43–52.
9.
BostwickJ. Michael. 2012. “Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana.” Mayo Clinic Proceedings87(2):172–86.
10.
BradfordAshley C.BradfordW. David. 2017. “Factors Driving the Diffusion of Medical Marijuana Legalization in the United States.” Drugs: Education, Prevention and Policy24(1):75–84.
11.
BuchmanDaniel Z.HoAnitaGoldbergDaniel S.2017. “Investigating Trust, Expertise, and Epistemic Injustice in Chronic Pain.” Journal of Bioethical Inquiry14(1):31–42.
12.
BuryMichael. 1982. “Chronic Illness as Biographical Disruption.” Sociology of Health & Illness4(2):167–82.
13.
CaulkinsJonathan P.ReuterPeter. 2021. “Ending the War on Drugs Need Not, and Should Not, Involve Legalizing Supply by a For-Profit Industry.” American Journal of Bioethics21(4):31–35.
14.
CharmazKathy. 1995. “The Body, Identity, and Self: Adapting to Impairment.” The Sociological Quarterly36(4):657–80.
15.
DeleuzeGilles. 1970. Spinoza: Practical Philosophy. San Francisco, CA: City Lights Books.
16.
DeleuzeGilles. 1992. “Postscript on Societies of Control.” 59(Winter):3–7.
17.
DeleuzeGillesGuattariFelix. 1972. Anti-Oedipus: Capitalism and Schizophrenia. New York, NY: Penguin Classics.
18.
DeleuzeGillesGuattariFelix. 1987. A Thousand Plateaus: Capitalism and Schizophrenia. Minneapolis: University of Minnesota Press.
19.
DiounCyrus. 2018. “Negotiating Moral Boundaries: Social Movements and the Strategic (Re)definition of the Medical in Cannabis Markets.” Pp. 53–82 in Social Movements, Stakeholders and Non-market Strategy: Research in the Sociology of Organizations. Vol. 56, edited by BriscoeF.KingB. G.LeitzingerJ., Leeds, UK: J. Emerald Publishing.
20.
DuffCameron. 2010. “Enabling Places and Enabling Resources: New Directions for Harm Reduction Research and Practice.” Drug and Alcohol Review29:337–44.
21.
DuffCameron. 2011. “Reassembling (Social) Contexts: New Directions for a Sociology of Drugs.” International Journal of Drug Policy22(6):404–406.
22.
DuncanTristanDuffCameronSebarBernadetteLeeJessica. 2017. “‘Enjoying the Kick’: Locating Pleasure within the Drug Consumption Room.” International Journal of Drug Policy49:92–101.
23.
EscohotadoAntonio. 1999. A Brief History of Drugs: From the Stone Age to the Stoned Age. Rochester, VT: Park Street Press.
24.
FirthCailin L.MaherJulie E.DilleyJulia A.DarnellAdamLovrichNicholas P.2019. “Did Marijuana Legalization in Washington State Reduce Racial Disparities in Adult Marijuana Arrests?”Substance Use and Misuse54(9):1582–87.
25.
FoxNick J.AlldredPam. 2017. Sociology and the New Materialism: Theory, Research, Action. London: Sage.
26.
GoodeErich. 1970. The Marijuana Smokers. New York, NY: Basic Books.
27.
GunadiChristianShiYuyan. 2022a. “Association of Recreational Cannabis Legalization with Cannabis Possession Arrest Rates in the U.S.” JAMA Network Open5(12):e2244922. doi:10.1001/jamanetwork open.2022.44922.
28.
GunadiChristianShiYuyan. 2022b. “Cannabis Decriminalization and Racial Disparity in Arrests for Cannabis Possession.” Social Science & Medicine293:114672. doi:10.1016/j.socscimed.2021.114672.
29.
HallJoanne M.FieldsBecky. 2015. “‘It’s Killing Us!’ Narratives of Black Adults about Microaggression Experiences and Related Health Stress.” Global Qualitative Nursing Research2. doi:10.1177/2333393615591569.
30.
HammersvikEirik. 2015. “Four Barriers and a Set of Values That Prevent Violence among Cannabis Growers.” International Journal of Drug Policy26(3):290–95.
31.
HeidtJonWheeldonJoahannes. 2022. “Data, Damn Lies, and Cannabis Policy: Reefer Madness and the Methodological Crimes of the New Prohibitionists.” Critical Criminology30(2):403–19.
IglerEva C.DefenderferEllenLangAmy C.BauerKathleenUihleinJuliaDaviesHobart W.2017. “Gender Differences in the Experience of Pain Dismissal in Adolescence.” Journal of Child Health Care21(4):381–91.
34.
JoshiSpruhaDoonanSamantha M.PamplinJohn R.II. 2023. “A Tale of Two Cities: Racialized Arrests following Decriminalization and Recreational Legalization of Cannabis.” Drug and Alcohol Dependence249:109911. doi:10.1016/j.dru galcdep.2023.109911.
35.
JuusoPäiviSkärLisaOlssonMalinSöderbergSiv. 2011. “Living with a Double Burden: Meanings of Pain for Women with Fibromyalgia.” International Journal of Qualitative Studies on Health and Well-being6(3):7184. doi:10.3402/qhw.v6i3.7184.
36.
KhuranaS.FedorovaEkaterina V.KaurHarjotMitchellAllisonKosdonSariAtaiantsJannaConnBridgidWongCarolyn F.LankenauStephen E.2022. “‘I Feel Validated’: Participation in a Medical Cannabis Program in the Context of Legalized Recreational Use.” Journal of Drug Issues52(4):601–61.
37.
KilmerBeauMacCounRobert J.2017. “How Medical Marijuana Smoothed the Transition to Marijuana Legalization in the United States.” Annual Review of Law and Social Science13:181–202.
38.
KinneyAlexander. 2023. “Sumptuary Administration: How Contested Market Actors Shape the Trajectory of Policy When Regulated under Fragmented Governance.” Law & Policy45(4):507–29.
39.
KleberHerbert D.DupontRobert L.2012. “Physicians and Medical Marijuana.” The American Journal of Psychiatry169(6):564–68.
40.
KondradElinReidAlfred. 2013. “Colorado Family Physicians’ Attitudes toward Medical Marijuana.” Journal of the American Board of Family Medicine26(1):52–60.
41.
LagalisseErica. 2018. “The Dangers of Health and Safety: Marijuana Legalization as Frontier Capitalism.” Journal of Ethnobiology38(4):473–88.
42.
LansingMichael J.2021. “Policing Politics: Labor, Race, and the Police Officers Federation of Minneapolis, 1945–1972.” Minnesota History67(5):226–38.
43.
Lavie-AjayiMayaShvartzmanPesach. 2019. “Restored Self: A Phenomenological Study of Pain Relief by Cannabis.” Pain Medicine20(11):2086–93.
44.
MalinsPeta. 2004. “Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use.” Janus Head7(1):84–104.
45.
MarkovicIvan. 2019. “Out of Place, out of Time: Towards a More-than-Human Rhythmanalysis of Smoking.” Cultural Geographies26(4):487–503.
46.
McCarthyKathleen T.2004. “Conversations about Medical Marijuana between Physicians and Their Patients.” The Journal of Legal Medicine25(3):333–49.
47.
McLeodKim. 2017. Well-Being Machine: How Health Emerges from the Assemblages of Everyday Life. Durham, NC: Carolina Academic Press.
48.
MeizeMikala R.StohrMary K.WillitsDale W.SolenstenBrittanyHamptonMonique M.MakinDavid A.LovrichNicholas P.HemmensCraigStantonDuane L.Sr. 2022. “The Intersection of Gender, Race, and Arrest in the Era of Cannabis Legalization.” Crime and Delinquency. doi:10.1177/00111287221083892.
49.
MelnikovSemyonAboavAnatShalomEsterPhriedmanShoshiKhalailaKhaled. 2020. “The Effect of Attitudes, Subjective Norms and Stigma on Healthcare Providers’ Intention to Recommend Medicinal Cannabis to Patients.” International Journal of Nursing Practice27(1):e12836. doi:10.1111/ijn.12836.
50.
MillerLeslie R.PeckMitchell B.2020. “A Prospective Examination of Racial Microaggressions in the Medical Encounter.” Journal of Racial and Ethnic Health Disparities7(3):519–27.
MosseyJana M.2011. “Defining Racial and Ethnic Disparities in Pain Management.” Clinical Orthopaedics and Related Research469(7):1859–70.
54.
NewhartMichelleDolphinWilliam. 2019. The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience. New York, NY: Routledge.
55.
O’BrienPatrick K.2013. “Medical Marijuana and Social Control: Escaping Criminalization and Embracing Medicalization.” Deviant Behavior34(6):423–43.
56.
Owusu-BempahAkwasiLuscombeAlex. 2021. “Race, Cannabis and the Canadian War on Drugs: An Examination of Cannabis Arrest Data by Race in Five Cities.” International Journal of Drug Policy91:102937. doi:10.1016/j.drugpo.2020.102937.
57.
Palacios-CeñaDomingoNeira-MartínBeatrizSilva-HernándezLorenzoMay-CanalejoDiegoFlorencioLidiane LimaFernandez-de-las-PenasCesarGarcia-MorenoHectorGarcia-AzorinDavidCuadradoMaria Luz. 2017 “Living with Chronic Migraine: A Qualitative Study on Female Patients’ Perspectives from a Specialized Headache Clinic in Spain.” BMJ Open7(8):e017851. doi:10.1136/bmjo pen-2017-017851.
58.
PattonPaul. 2000. Deleuze and the Political. London: Routledge.
59.
PedersenWillySandbergSveinung. 2013. “The Medicalization of Revolt: A Sociological Analysis of Medical Cannabis Users.” Sociology of Health & Illness35(1):17–32.
60.
PolsonMichaelBodwitchHekia. 2021. “Prohibited Commoning: Cannabis and Emancipatory Legalization.” Elementa: Science of the Anthropocene9(1):1–16.
61.
PughAllison J.2013. “What Good Are Interviews for Thinking about Culture? Demystifying Interpretive Analysis.” American Journal of Cultural Sociology1(1):42–68.
62.
RaceKane. 2011. “Drug Effects, Performativity and the Law.” International Journal of Drug Policy22(6):410–12.
63.
ReidMatt. 2023. “How the Incomplete Medicalization of Cannabis Shapes Patient Experiences.” Sociological Focus56(1):97–114.
64.
ScavoneJ. L.SterlingR. C.Van BockstaeleE. J.2013. “Cannabinoid and Opioid Interactions: Implications for Opiate Dependence and Withdrawal.” Neuroscience248(17):637–54.
65.
SchaferGráinnePrkachinKenneth M.KaseweterKimberly A.WilliamsAmanda C. D.2016. “Health Care Providers’ Judgments in Chronic Pain: The Influence of Gender and Trustworthiness.” Pain157(8):1618–25.
66.
SinghalAsthaYu-YuTienHsiaRenee Y.2016. “Racial–Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse.” PLoS One11(8):e0159224. doi:10.1371/journal.pone.0159224.
67.
SmithAlexandraOlsonRebecca E.da CostaNathalia CordeiroCuertonMaddisonHardyJanetGoodPhilip. 2023. “Qualify of Life beyond Measure: Advanced Cancer Patients, Well-Being, and Medicinal Cannabis.” Sociology of Health & Illness45(8):1709–29.
68.
SpetzJoanneChapmanSusan A.BatesTimothyJuraMatthewSchmidtLaura A.2019. “Social and Political Factors Associated with State-Level Legalization of Cannabis in the United States.” Contemporary Drug Problems46(2):165–79.
69.
SteelRyan T.2022. “Medicalizing the Menace? The Symbiotic Convergence of Medicine and Law Enforcement in the Medicalization of Marijuana in Minnesota.” Sociology of Health & Illness44(8):1324–43.
70.
TimmermansStefanGabeJonathan. 2002. “Introduction: Connecting Criminology and Sociology of Health and Illness.” Sociology of Health & Illness24(5):501–16.
71.
TimmermansStefanTavoryIddo. 2012. “Theory Construction in Qualitative Research: From Grounded Theory to Abductive Analysis.” Sociological Theory30(3):167–86.
72.
WeilAndrew. 1972. The Natural Mind: A New Way of Looking at Drugs and the Higher Consciousness. Boston, MA: Houghton Mifflin Co.
73.
WeisBethWilson-PoeAdrianne R.2018. “Emerging Evidence for Cannabis’ Role in Opioid Use Disorder.” Cannabis and Cannabinoid Research3(1):179–89.
74.
WheeldonJohannesHeidtJon. 2023. “The Paradoxes of Normalization: Cannabis as Nuisance Crime, Medicine, and Consumer Good in British Columbia before and after Legalization.” Deviant Behavior44(7):989–1012.
75.
WillitsDale W.SolenstenBrittanyMeizeMikalaStohrMary K.MakinDavid A.HemmensCraigStantonDuane L.LovrichNicholas P.2022. “Racial Disparities in the Wake of Cannabis Legalization: Documenting Persistence and Change.” Race and Justice. doi:10.1177/21533687221087355.
76.
ZarhinDanaNegevMayaVulfsonsSimonSznitmanSharon R.2018. “Rhetorical and Regulatory Boundary-Work: The Case of Medical Cannabis Policy-Making in Israel.” Social Science & Medicine217:1–9.
77.
ZolotovYuvalVulfsonsSimonZarhinDanaSznitmanSharon. 2018. “Medical Cannabis: An Oxymoron? Physicians’ Perceptions of Medical Cannabis.” International Journal of Drug Policy57:4–10.
